You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

HEXABRIX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hexabrix, and what generic alternatives are available?

Hexabrix is a drug marketed by Guerbet and is included in one NDA.

The generic ingredient in HEXABRIX is ioxaglate meglumine; ioxaglate sodium. Additional details are available on the ioxaglate meglumine; ioxaglate sodium profile page.

Drug patent expirations by year for HEXABRIX
Recent Clinical Trials for HEXABRIX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GuerbetPhase 4
NYU Langone HealthPhase 4
New York University School of MedicinePhase 4

See all HEXABRIX clinical trials

US Patents and Regulatory Information for HEXABRIX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Guerbet HEXABRIX ioxaglate meglumine; ioxaglate sodium INJECTABLE;INJECTION 018905-002 Jul 26, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HEXABRIX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Guerbet HEXABRIX ioxaglate meglumine; ioxaglate sodium INJECTABLE;INJECTION 018905-002 Jul 26, 1985 ⤷  Try a Trial ⤷  Try a Trial
Guerbet HEXABRIX ioxaglate meglumine; ioxaglate sodium INJECTABLE;INJECTION 018905-002 Jul 26, 1985 ⤷  Try a Trial ⤷  Try a Trial
Guerbet HEXABRIX ioxaglate meglumine; ioxaglate sodium INJECTABLE;INJECTION 018905-002 Jul 26, 1985 ⤷  Try a Trial ⤷  Try a Trial
Guerbet HEXABRIX ioxaglate meglumine; ioxaglate sodium INJECTABLE;INJECTION 018905-002 Jul 26, 1985 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for HEXABRIX

See the table below for patents covering HEXABRIX around the world.

Country Patent Number Title Estimated Expiration
United Kingdom 1488903 ⤷  Try a Trial
Germany 2524059 ⤷  Try a Trial
Czechoslovakia 207563 METHOD OF MAKING THE DERIVATIVES OF THE ACID 2,4,6-TRIIOD-5/BIS/2,4,6-TRIIODPHENYL/-CARBOMOYLMETHYL/AMINOACETAMIDO/-BENZOO,UTILIZABLE AS CONTRAST SUBSTANCES IN RADIOGRAPHY ⤷  Try a Trial
Canada 1086328 SUBSTANCES DE CONTRASTE POUR RAYONS X (X-RAY CONTRAST MEDIA) ⤷  Try a Trial
Japan S613779 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.